Pretreatment With CPA-EE, Metformin and Myoinositol in PCOS With High AMH
Key facts
- Who runs it
- Mst.Sumyara Khatun
- Where
- Bangladesh1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 68 people enrolled
- Started
- 12 Aug 2024
- Ended
- 20 Feb 2026
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Cyproterone Acetate, Ethinyl Estradiol Drug Combination
- Metformin 500 mg
- Myoinositol 750mg
- Record updated
- 7 April 2026
Who can take part
- Age
- 18 years to 35 years
- Sex
- Women only
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 12 criteriaShow less
Who can take part
- PCOS
- 18-35 years
- Body Mass Index (BMI): 18.5-29.9 kg/m²
- Infertility
- Serum AMH level ≥ 5ng/ml
Who cannot take part
- Women having metformin or other drug that could influence hormone metabolism at least 3 months before the study
- Endocrine disorder (Hyperprolactinaemia,Uncontrolled hypothyroidism , Diabetes mellitus (DM) type 2,congenital adrenal hyperplasia,cushing syndrome)
- Any known case of pulmonary,cardiac,hepatic \& renal disease
- Any contraindications to metformin, myoinositol, letrozole \& CPA-EE ie. obesity, thromboembolism, breast carcinoma etc \& hypersensitivity to these drugs
- Serum AMH level > 10 ng/ml
- Women with infertility other than anovulation due to PCOS(bilateral tubal block,uterine factor,endometriosis)
- Abnormal semen parameter
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Women with PCOS with high AMH randomly allocated into group A \& B.Cyproterone acetate plus ethinyl estradiol,metformin \& myoinositol in group A and Cyproterone acetate plus ethinyl estradiol \& metformin are given in group B.Then letrozole 5 mg day 2 to day 6 is given \& ovarian response is seen in day 12 for 3 subsequent 3 months .
The 2 groups in the trial
- Experimental armCyproterone acetate 2 mg plus ethinyl estradiol 35 mcg once daily ,metformin 500 mTreatment being tested
Cyproterone acetate 2 mg plus ethinyl estradiol 35 mcg once daily ,metformin 500 mg 3 times daily \& Myoinositol 750 mg 3 times daily for 3 months.After 3 months of pretreatment letrozole 5 mg daily for 5 days from day 2 to day 6 of menstrual cycle is given Ovarian response is seen by day 12 folliculometry observing developing follicle ,mature follicle and endometrial thickness and day 21 serum progesterone.
Treatment: Cyproterone Acetate, Ethinyl Estradiol Drug Combination, Metformin 500 mg, and Myoinositol 750mg
- Comparator armCyproterone acetate 2 mg plus ethinyl estradiol 35 mcg once daily ,metformin 500 mgExisting treatment, for comparison
Cyproterone acetate 2 mg plus ethinyl estradiol 35 mcg once daily ,metformin 500 mg 3 times daily for 3 months.After 3 months of pretreatment letrozole 5 mg daily for 5 days from day 2 to day 6 of menstrual cycle is given Ovarian response is seen by day 12 folliculometry observing developing follicle ,mature follicle and endometrial thickness and day 21 serum progesterone.
Treatment: Cyproterone Acetate, Ethinyl Estradiol Drug Combination and Metformin 500 mg
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 7 April 2026